suMMARY The structural effect of prostaglandin E1 on the pulmonary circulation in pulmonary atresia has been studied by applying quantitative morphometric techniques to the injected and inflated lungs of eight babies who had received prostaglandin E1 for between 30 hours and 12 days.
arteries per unit area of lung was greater in prostaglandin El treated than in untreated cases.
Infusion of prostaglandin El is now the ideal emergency treatment for pulmonary atresia, but the findings in the present study suggest that it should be given for as short a time as possible before the pulmonary blood flow is increased by surgical treatment.
Prostaglandin El (PGEj) dilates the ductus arteriosus' and is therefore used in the emergency treatment of newborn infants with pulmonary atresia.2 The effect of PGE, on the lungs of such patients is unknown. Acute experiments on healthy fetal and newborn goats,3 4 and in the adult animal in a variety of species,5-7 demonstrate a fall in pulmonary vascular resistance. In the human adult infusion on PGE, lowers pulmonary vascular resistance, considerably in the presence of pulmonary hypertension, but only slightly in the normal lung.8 9 A quantitative morphometric study of the lungs of untreated children dying with pulmonary atresia showed a reduction in pulmonary arterial muscle, pre-and intra-acinar arterial size, and intra-acinar arterial number,'0 compared with normal.1" 12 In the present study the effect of PGE, on the lung vessels of patients with pulmonary atresia, dying at a similar age, has been analysed using the same techniques. (Fig. 1) . Aneurysmal dilatation of the distal half, the muscular portion of the arterial pathway, occurred in all cases, but was pronounced in four (cases 4, 5, 6, and 7) (Fig. 1) . In these four cases, between three and seven segments were involved in each lung.
GENERAL HISTOLOGICAL FEATURES
In all cases the arteries accompanying small bronchi and bronchioli were larger than normal relative to the size of the airway and appeared tortuous. Tortuosity extended from at least the level of the small bronchi down the arterial pathway to respiratory bronchiolar level, involving muscular, partially muscular, and non-muscular vessels. Dissecting aneurysms were seen in four cases, involving the preacinar* muscular arteries. The arteries also appeared abnormally thin walled. The elastic fibres and muscle cells were arranged in a less compact fashion than normal, particularly the outermost elastic lamina which frequently peeled away from the vessel at some point around the circumference. Oedema produced small clear spaces, which were variable in size and frequently separated the medial components. These spaces showed no eosinophilia.
Dilatation of the lymphatic channels was a striking feature in cases 1 to 4. In these four cases the subpleural lymphatic channels, those in the *An acinus is all the lung tissue distal to a terminal bronchiolus.
connective tissue septa within the lung and those in the perivascular sheath were abnormally distended. Lymphatic dilatation was present but less distinct in cases 5 and 6. In all cases the veins also appeared unduly prominent, appearing larger and more circular than is normal. Vein wall structure appeared normal.
ARTERIAL SIZE
On the postmortem arteriogram the lumen diameter of the preacinar arteries was generally greater than that of untreated patients dying with pulmonary atresia and similar to that seen in the normal child of similar age (Fig. 2) . The difference in size between untreated and PGE1 treated cases of pulmonary atresia was pronounced along the proximal half of the pathway, which consists of elastic arteries. Further along the pathway, however, microscopical examination revealed conspicuous dilatation of the preacinar muscular vessels.
By contrast, within the acinus microscopical measurement showed a reduction in external diameter in seven cases (Table 2) . At nearly all levels along the arterial pathway the arteries were smaller, even at 15 days, than is seen in the normal lung at three days, and were similar in size to those of untreated patients. In the remaining case (case 8) the findings were difficult to interpret because there were no normal or untreated cases of pulmonary atresia of similar age with which to make a comparison.
NUMBER OF INTRA-ACINAR ARTERIES
In all cases treated with PGE1, the arterial volume proportion was greater than in untreated cases, and was even greater than normal. The arterial volume proportion varied between 6-9 and 9 4 per cent in PGE1 treated cases as compared with 1-5 to 3'9 per Fig. 1 (Fig. 3) . In arteries larger than 250 tim, in four cases (cases 1, 2, 3, and 8) muscularity was similar to that seen in untreated cases and below the normal for age. In the remaining four cases muscularity was less than that seen in untreated cases and even less than that seen in the normal adult (Fig. 4) . Two of the three cases showing the greatest reduction in muscularity in arteries of all size groups also showed the most severe and widespread picture of aneurysmal dilatations on the postmortem arteriogram.
Extension of muscle along the arterial pathway Examination of the structure of arteries in relation both to their size and to their position along the arterial pathway showed that in seven cases of pulmonary atresia given PGE1 muscle did not extend as far to the periphery as in either untreated cases of pulmonary atresia or in normal children of similar age. The smaller arteries contained less muscle. The size of the smallest arteries entirely surrounded by a muscle coat was increased and larger arteries had a partially rather than an entirely muscular coat (Table 3) . Examination of the structure of arteries accompanying the peripheral airways showed that at terminal bronchiolar level a greater proportion of arteries had-a partially muscular rather than an entirely muscular wall (Table 4 ). More peripherally, at respiratory bronchiolar and alveolar duct level, more arteries had a muscular rather than a partially muscular wall structure. In case 8, the oldest child dying at 50 days, the distribution of muscle along the arterial pathway was normal.
SUMMARY OF PATHOLOGICAL FINDINGS
Comparison of the PGE, treated with the untreated cases of pulmonary atresia and with the normal showed the following: the preacinar arteries were dilated and tortuous, but the intra-acinar arteries remained abnormally small, similar in size to those of untreated cases. The number of intra-acinar arteries per unit area of lung was increased in relation to untreated cases and even exceeded the number found in the normal newborn lung. The lymphatic channels were abnormally distended in four cases. The walls of the muscular and partially muscular arteries appeared oedematous, the media was less compact than normal, and the outer elastic lamina was frequently broken. In the large muscular arteries localised aneurysmal dilatations occurred and dissecting aneurysms were present microscopically in four cases. Pulmonary arterial smooth muscle was reduced. Percentage arterial medial thickness was reduced, and muscle did not extend as far along the arterial pathway as in either the normal or untreated cases of pulmonary atresia.
Discussion
In this series of newborn children with pulmonary atresia treated with PGE,, the most striking abnormality was a reduction in pulmonary arterial smooth muscle. This feature cannot be attributed to the increase in blood flow achieved by dilating the ductus arteriosus. In congenital heart disease an abnormally high flow is associated with increased pulmonary arterial muscle, even when there is little increase in pressure,20 and in pulmonary atresia or stenosis an aortopulmonary anastomosis is frequently associated with increased muscularity. ' .'. i., ."
group.bmj.com on May 29, 2017 -Published by http://heart.bmj.com/ Downloaded from most susceptible to change, exaggerated the normal process of adaptation to extrauterine life. It is interesting to observe that in the normal child the plasma prostaglandin E concentrations are higher during the first 24 hours than at any other time of life, falling rapidly by the second and third day.3' By contrast, Manchester et al.3" reported two infants born of mothers given the prostaglandin synthetase inhibitor, indomethacin, who experienced persistence of the fetal circulation, attributed to an abnormally high pulmonary vascular resistance, in the absence of a cardiac malformation or parenchymal lung disease. Indomethacin treated neonatal goats show an exaggerated response to hypoxia." Levin et al.'4 reported an increase in pulmonary arterial medial width/external diameter ratio in two children born of mothers who took either salicylates or indomethacin during pregnancy. In one patient the ductus arteriosus remained patent, suggesting a direct effect of prostaglandin synthetase inhibitor on the pulmonary vascular smooth muscle, rather than the increased muscularity being secondary to premature closure of the ductus arteriosus.
Infusion of PGE, appeared to weaken the walls of muscular pulmonary arteries. This did not occur in untreated cases of pulmonary atresia, nor in a 15-day-old baby dying several days after a successful Waterston-Cooley anastomosis had been performed, but who had not received PGE,.10
Infusion of PGE, also appeared to have a weakening effect on the wall of the ductus arteriosus in six of the seven cases in the present series in which the ductus was examined (A C Gittenberger-de Groot, 1979, personal communication) . In four other babi s there was 'oedema of the media with separation of medial components by clear spaces, pathological interruption of the internal elastic lamina and intimal laceration' after PGE, infusion,3' changes similar to those found in the pulmonary arteries of the present series. Microscopical examination showed widespread distension of the lymphatic channels in several cases. PGE, increases the permeability of small blood vessels in the skin, doing so at a dose as low as 50 ng, and in cremaster muscle.36 Studies on the sensitised guinea-pig lung showed that release of PGE, from the lung was associated with leakage of fluid.37 If PGE, does, indeed, increase the permeability of the small pulmonary vessels there are important clinical implications. In the normal lung, the rate of lymph clearance is higher during the first hours of life than at any other time as fetal lung fluid is cleared.38 In pulmonary atresia, therefore, PGE, treatment would be better started after this time, if at all possible.
The present series of cases is too small to show whether or not there is a clear relation between dose, duration, and structural change. There was, however, a progressive reduction in muscularity the greater the duration of infusion in children started on PGE, during the first 24 hours of life (Fig. 3) . The two cases receiving PGE, for the longest period of time had the most severe and widespread aneurysmal dilatation of muscular pulmonary arteries. In addition, children given PGE, for a similar length of time showed a similar structural response.
Several babies survived for some time after the PGE, infusion was stopped, raising the possibility that the structural changes seen at necropsy might not entirely represent the action of the drug. The structural findings in these babies did not, however, differ in kind from those found in infants dying while being infused with the drug. The most severe change occurred in three cases dying at between three and 13 days after stopping the infusion, suggesting that whatever change had been induced by the PGE1 had either persisted or, indeed, had progressed after stopping the drug. The pulmonary blood flow probably never increased sufficiently in any patient to a point at which stimulation of vascular smooth muscle development might have occurred. Case 8 showed less structural change than the other seven cases. This child might, however, have had a higher pulmonary blood flow and thus more pulmonary arterial muscle initially because treatment was not required until 40 days of age. At necropsy, the ductus arteriosus was relatively large and had the structural characteristics of a persistent ductus arteriosus rather than those of a normally closing ductus, as found in the six out of seven other cases examined (A C Gittenberger-de Groot, 1979, personal communication) . In addition, starting treatment with PGE1 at 40 days might produce less structural change than when started within the first hours of life.
CLINICAL IMPLICATIONS
Infusion of PGE1 in babies with pulmonary atresia maintains the patency of the ductus arteriosus and ensures perfusion of the lung. In the present series, PGE1 infusion was associated with dilatation of the preacinar arteries, a reduction in arterial muscularity, and an increase in number of intra-acinar pulmonary arteries. These effects are beneficial, since they are compatible with a reduction in pulmonary vascular resistance. Unfortunately, however, PGE1 appears to have a weakening effect on the wall of muscular pulmonary arteries, an effect that may have been accentuated in these cases since pulmonary atresia is normally associated with a reduction in muscularity. Furthermore, the PGE1 was generally used soon after birth when the pulmonary circulation is adapting most rapidly to extrauterine life, and, since adaptation is normally associated with a reduction in muscularity, the lung may have been particularly vulnerable to PGE1 at this time. The pathological findings suggest that increased vascular permeability might be a second disquieting feature in the newborn infant.
The extent to which the structural changes in the muscular pulmonary arteries are reversible is unknown. Muscularity will, however, probably increase to a normal level given an increase in pulmonary arterial pressure and flow, just as muscularity increases abnormally in the presence of pulmonary hypertension.
Thus, the structural findings in the pulmonary circulation of children with pulmonary atresia treated with PGE1 suggest that the drug is best started after the first few hours of life and given until the arterial oxygen tension is increased and the child's condition has improved sufficiently for him to undergo surgical treatment.
The reduction in arterial muscularity seen in the present series suggests that PGE1 may have a wider application in the newborn period. In particular, it may be useful in the management of patients with a normal heart in,, whom pulmonary vascular resistance remains raised after birth and in children with congenital heart disease who are bom with abnormally thick-walled muscular pulmonary arteries.
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